Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at Morgan Stanley 23rd Annual Global

Core Insights - Arrowhead Pharmaceuticals is represented by CEO Christopher Anzalone and CMO James Hamilton at the Morgan Stanley Global Healthcare Conference [1]. Group 1 - The presentation is led by Michael Ulz, an equity analyst at Morgan Stanley, who introduces the team from Arrowhead Pharmaceuticals [1]. - The conference serves as a platform for Arrowhead Pharmaceuticals to engage with investors and discuss their strategies and developments in the biotech sector [1][3].